Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
Clinical trial NCT03337022 · COMPLETED
Trial details
- NCT number
- NCT03337022
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-04
- Primary completion
- 2019-04-26
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.